Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

GeneDx Holdings (WGS) Shares Outstanding (2020 - 2022)

Historic Shares Outstanding for GeneDx Holdings (WGS) over the last 3 years, with Q4 2022 value amounting to $388.5 million.

  • GeneDx Holdings' Shares Outstanding rose 6011.33% to $388.5 million in Q4 2022 from the same period last year, while for Dec 2022 it was $388.5 million, marking a year-over-year increase of 6011.33%. This contributed to the annual value of $388.5 million for FY2022, which is 6011.33% up from last year.
  • According to the latest figures from Q4 2022, GeneDx Holdings' Shares Outstanding is $388.5 million, which was up 6011.33% from $381.4 million recorded in Q3 2022.
  • GeneDx Holdings' Shares Outstanding's 5-year high stood at $388.5 million during Q4 2022, with a 5-year trough of $124.0 in Q2 2020.
  • Moreover, its 3-year median value for Shares Outstanding was $240.2 million (2021), whereas its average is $170.9 million.
  • As far as peak fluctuations go, GeneDx Holdings' Shares Outstanding skyrocketed by 19370183709.68% in 2021, and later surged by 5880.27% in 2022.
  • GeneDx Holdings' Shares Outstanding (Quarter) stood at $130557.0 in 2020, then skyrocketed by 185755.68% to $242.6 million in 2021, then skyrocketed by 60.11% to $388.5 million in 2022.
  • Its last three reported values are $388.5 million in Q4 2022, $381.4 million for Q3 2022, and $379.9 million during Q2 2022.